DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced the U.S. Food and Drug Administration (FDA) ...

Ten healthy males received an intrajejunal (i.j.) glucose infusion; data regarding blood glucose, and plasma insulin, glucagon and GLP-1 have been reported previously. 4 These, together with plasma ...

Amphastar Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for Dextrose injection 50% in the 50 ml Luer-Jet Prefilled ...

Expert Rev Endocrinol Metab. 2012;7(4):433-443. It is not recommended to stop an already initiated insulin infusion, but rather to introduce dextrose infusion with a 'two-bag system' if the blood ...

New clinical data suggests intra-articular injections of hypertonic dextrose are safe and effective at alleviating knee pain caused by osteoarthritis, a condition affecting nearly 30 million Americans ...

Am J Health Syst Pharm. 2005;62(21):2260-2264. Verify that the patient is receiving some source of exogenous glucose before initiating infusion (e.g., total parenteral nutrition [TPN], i.v. fluids ...

RANCHO CUCAMONGA, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) approved the Company’s ...

According to the Company, intravenous administration of the affected product could lead to “site specific infections as well as serious systemic infections which may be life-threatening.” SterRx, LLC ...